Each year, heart disease and related conditions kill 700,000
Americans, but new studies are questioning old assumptions about
the best methods for treating vascular disease.
According to Dr. Conrad Maulfair, director of the Maulfair
Medical Center, (www.drmaulfair.com/ in Topton, Pa., most
Americans don't understand that heart disease develops long
before the first symptoms appear. "While the symptoms of
atherosclerosis, commonly referred to as hardening of the
arteries, may appear suddenly as chest pain or a stroke, the
disease may have begun 20, 30, or even 40 years earlier."
A 2005 study published in the journal Evidence Based Integrative
Medicine highlights the fact that people with vascular disease
who underwent non-invasive intravenous chelation therapy
experienced fewer cardiac events in the subsequent three years
than those treated with bypass surgery, angioplasty, or other
conventional medical therapy.
In 1963, Congress began annual legislation calling for the
President to proclaim February "American Heart Month," and the
American Heart Association uses this as a call to action for
Americans to get educated as to the causes and treatments that
can stem this alarming mortality rate.
"Even those who understand that atherosclerosis develops slowly
over long periods of time may have misconceptions about the
factors that contribute to the disease and draw the wrong
conclusions about its prognosis," says Dr. Maulfair,
"I doubt there is a person in the United States over 40 who
doesn't believe, with certainty, that cholesterol is bad and
that it causes blocked arteries. Most people regard high levels
of cholesterol in the diet and in blood akin to a death sentence
from atherosclerotic disease," he notes.
On the contrary, Dr. Maulfair says that only a certain type of
cholesterol makes up a significant part of the plaque that
blocks arteries. "Damaged LDL cholesterol is the main ingredient
in plaque, not undamaged, normal cholesterol."
According to Dr. Maulfair, free radicals - reactive molecules
that rob cells and tissues of electrons - damage LDL
cholesterol, which is then more likely to adhere to the arterial
wall. "Damage from free radicals left unchecked day after day,
week after week, year after year results in the inability of
cells and tissues to function normally, and can lead to the
destruction, decreased function, and death of those cells."
This information has profound implications for the way
atherosclerosis is perceived and treated. "When a diagnosis is
made," explains Dr. Maulfair, "it is generally accepted by both
the patient and the healthcare professional that the disease
will be present for the rest of the patient's life." But this is
not necessarily so, according to Dr. Maulfair and he adds, "when
the underlying causes of the condition - in this case, free
radical damage - are treated, the disease process can often be
slowed or reversed. "
The most promising candidate for the eradication of free
radicals is intravenous chelation therapy. Chelation works by
binding to the toxic metals and excessive iron and copper in the
body that cause free radical damage, allowing those toxins to be
excreted through the urine. Likewise, chelation lowers the
body's level of metastic calcium, which is a form of calcium
that deposits itself in the walls of the arteries prior to the
formation of arterial plaque.
Dr. Maulfair explains there are three components of a chelation
therapy program. "First, intravenous chelation treatment removes
the metastic calcium and the iron and copper that accelerate
free radical damage. It also removes toxic metals, such as lead
and cadmium. Second, specific mineral nutrients and antioxidants
essential for healthy cell function are taken orally. Third, a
comprehensive diet and exercise program supports the progress
Dr. Maulfair stresses education, and sums up: "It's important to
understand that heart disease is not necessarily a chronic,
degenerative disease with no hope for improvement, but that it
can be treated and, in fact, reversed."